NVAX: $55+ Target very Reasonable, hoping for around $65

First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. That being said, I have a few quick insights. Novavax is about to start the human clinical trials for a Coronavirus vaccine, and the recent already expected price retracement by investors, the strong buy rating, and the positive news may have this stock start to rally and you might want to consider this as a buy pre-market hours even.